sprycel-hcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Sitemap: | ||
Meta Tags
| Title | SPRYCEL® (dasatinib) for Healthcare |
| Description | PUT PATIENTS ON A PATH TO Find SPRYCEL® indicated for the treatment of pediatric patients with newly diagnosed Ph+ acute lymphoblastic leukemia (ALL) with chemotherapy&for adults & children with Philadelphia Chromosome-positive Chronic Myeloid Leukemia |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 165.89.235.20 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
sprycel-hcp.com Valuation
|
US$4,935,767
Last updated: 2023-05-12 03:40:14
sprycel-hcp.com has Semrush global rank of 2,144,409. sprycel-hcp.com has an estimated worth of US$ 4,935,767, based on its estimated Ads revenue. sprycel-hcp.com receives approximately 569,512 unique visitors each day. Its web server is located in United States, with IP address 165.89.235.20. According to SiteAdvisor, sprycel-hcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,935,767 |
| Daily Ads Revenue | US$4,557 |
| Monthly Ads Revenue | US$136,683 |
| Yearly Ads Revenue | US$1,640,194 |
| Daily Unique Visitors | 37,968 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| sprycel-hcp.com. | A | 86400 | IP: 165.89.235.20 |
| sprycel-hcp.com. | NS | 86400 | NS Record: ns4.bms.com. |
| sprycel-hcp.com. | NS | 86400 | NS Record: ns1.bms.com. |
| sprycel-hcp.com. | NS | 86400 | NS Record: ns2.bms.com. |
| sprycel-hcp.com. | NS | 86400 | NS Record: ns3.bms.com. |
| sprycel-hcp.com. | MX | 86400 | MX Record: 10 chimera.bms.com. |
| sprycel-hcp.com. | MX | 86400 | MX Record: 20 loki.bms.com. |
| sprycel-hcp.com. | TXT | 86400 | TXT Record: 314xkg38lwk87bl6xf76vs5gc1zc11ly |
| sprycel-hcp.com. | TXT | 86400 | TXT Record: 6v63y8v171mhtd5397kvx48yc7vhwltw |
HtmlToTextCheckTime:2023-05-12 03:40:14
| This site is intended for US-based Healthcare Professionals only. SPRYCEL Patient Site BMS Resources Full Prescribing Information Indications INDICATIONS SPRYCEL ® (dasatinib) is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase Chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy SPRYCEL ® is indicated for the treatment of pediatric patients 1 year of age and older with: Newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase Efficacy Newly Diagnosed Patients Patients Resistant or Intolerant to Imatinib Safety and Management Newly |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: http://www.sprycel-hcp.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Date: Sat, 27 Nov 2021 08:28:53 GMT Set-Cookie: CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 27-Nov-2022 08:28:53 GMT; Max-Age=31536000 Cache-Control: no-cache,must-revalidate,max-age=0,no-store,private Expires: Thu, 01 Jan 1970 00:00:00 GMT X-Cnection: close Set-Cookie: LSKey-c$CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 27-Nov-2022 08:28:53 GMT; Max-Age=31536000 X-XSS-Protection: 1; mode=block Content-Security-Policy: upgrade-insecure-requests Location: https://www.sprycel-hcp.com/ Connection: close HTTP/1.1 200 OK Date: Sat, 27 Nov 2021 08:28:53 GMT Set-Cookie: CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 27-Nov-2022 08:28:53 GMT; Max-Age=31536000 Cache-Control: public,max-age=600 X-Cnection: close Set-Cookie: LSKey-c$CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 27-Nov-2022 08:28:53 GMT; Max-Age=31536000 Strict-Transport-Security: max-age=31536004; includeSubDomains Content-Security-Policy-Report-Only: default-src https:; script-src https: 'unsafe-inline' 'unsafe-eval'; style-src https: 'unsafe-inline'; img-src https: data: blob: file:; frame-ancestors 'self' *.salesforce.com *.force.com *.visualforce.com *.documentforce.com; font-src https: data: blob: file:; connect-src 'self' https:; report-uri https://csp-report.force.com/_/ContentDomainCSPNoAuth?type=appserver X-XSS-Protection: 1; mode=block Content-Security-Policy: upgrade-insecure-requests X-Powered-By: Salesforce.com ApexPages P3P: CP="CUR OTR STA" Content-Language: en-US Expires: Sat, 27 Nov 2021 08:38:54 GMT Last-Modified: Sat, 27 Nov 2021 08:28:54 GMT Content-Security-Policy: frame-ancestors 'self' X-FRAME-OPTIONS: SAMEORIGIN Content-Type: text/html;charset=UTF-8 Connection: close |
sprycel-hcp.com Whois Information
Domain Name: SPRYCEL-HCP.COM Registry Domain ID: 1591009377_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-03-27T11:51:06Z Creation Date: 2010-03-31T19:36:59Z Registry Expiry Date: 2022-03-31T19:36:59Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BMS.COM Name Server: NS2.BMS.COM Name Server: NS3.BMS.COM Name Server: NS4.BMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-08T18:30:43Z <<< |